| Epidemiology from Literature | | Cohort | Year | Country | Test | Subjects | Positive (%) | Bibliography | | 1.1 - Asymptomatic | 2009 | Belgium | IgE | 26 | 0.000 | 20091121, Ebo DG
| | 1.1 - Asymptomatic | 2014 | Spain | IgE | 50 | 0.000 | 20140625, Armentia A
| | 1.10 - Any allergy symptom, Diagnosed | 2010 | Belgium | IgE | 86 | 6.976 | 20101214, Gadisseur R
| | 1.10 - Any allergy symptom, Diagnosed | 2010 | Italy | IgE | 16408 | 6.210 | 20100301, Scala E
| | 1.11 - Esophagitis, Diagnosed | 2013 | Netherlands | IgE | 76 | 7.900 | 20131020, van Rhijn BD
| | 1.11 - Esophagitis, Diagnosed | 2014 | Spain | IgE | 67 | 13.400 | 20140625, Armentia A
| | 1.11 - Esophagitis, Diagnosed | 2013 | Switzerland | IgE | 35 | 40.000 | 20130605, Simon D
| | 1.2.1 - Asthma, Diagnosed (Adults) | 2012 | Sweden | IgE | 96 | 3.130 | 20120528, Patelis A
| | 1.5 - Atopic Dermatitis, Diagnosed | 2013 | Germany | IgE | 140 | 6.430 | 20130111, Ott H
| | 1.5 - Atopic Dermatitis, Diagnosed | 2009 | Germany | IgE | 20 | 10.000 | 20091005, Ott H
| | 1.5 - Atopic Dermatitis, Diagnosed | 2014 | Korea, Republic of | IgE | 25 | 4.000 | 20140821, Choi JS
| | 1.9 - Pollen Allergy | 2014 | Spain | IgE | 50 | 4.000 | 20140625, Armentia A
| | 10.1 - Normal Control | 2012 | Belgium | IgE | 27 | 0.000 | 20110223, De Knop KJ
| | 3.2.1 - Source Sensitized (IgE) | 2009 | Belgium | IgE | 20 | 75.000 | 20091121, Ebo DG
| | 3.2.1 - Source Sensitized (IgE) | 2009 | Italy | IgE | 7 | 100.000 | 20091030, Quercia O
| | 4.1.5 - Heterologous Source Sensitized (IgE) | 2011 | Italy | IgE | 43 | 95.350 | 20110214, Villalta D
| | 4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE) | 2009 | Belgium | IgE | 37 | 18.910 | 20090826, Ebo DG
| | 4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE) | 2009 | Italy | IgE | 21 | 0.000 | 20090808, Krause S
| | 4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE) | 2014 | Spain | IgE | 130 | 15.600 | 20140401, Armentia A
| | 4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE) | 2012 | Spain | IgE | 55 | 14.500 | 20120726, Pedrosa M
| | 4.1.8 - Heterologous Source Sensitized (SPT, IgE) | 2012 | Spain | IgE | 68 | 13.200 | 20120726, Pedrosa M
| | 5.3.1 - Source Exposed (Symptoms, IgE) | 2012 | Belgium | IgE | 99 | 16.160 | 20110223, De Knop KJ
| | 5.3.1 - Source Exposed (Symptoms, IgE) | 2009 | Belgium | IgE | 22 | 4.550 | 20091121, Ebo DG
| | 5.3.1 - Source Exposed (Symptoms, IgE) | 2010 | Germany | IgE | 52 | 30.770 | 20100423, Ott H
| | 5.3.1 - Source Exposed (Symptoms, IgE) | 2001 | Germany | IgE | 50 | 24.000 | | | 5.3.1 - Source Exposed (Symptoms, IgE) | 2001 | Germany | IgE | 34 | 5.900 | | | 5.3.1 - Source Exposed (Symptoms, IgE) | 2008 | Portugal | IgE | 5 | 0.000 | 20080904, Rodrigues Alves R
| | 5.3.1 - Source Exposed (Symptoms, IgE) | 2005 | Spain | IgE | 31 | 0.000 | | | 5.4.1 - Source Exposed (Symptoms, SPT, IgE) | 2013 | Brazil | IgE | 11 | 9.090 | 20130429, Bueno de Sa A
| | 5.4.1 - Source Exposed (Symptoms, SPT, IgE) | 2012 | France | IgE | 97 | 19.000 | 20120706, Garnier L
| | 5.4.1 - Source Exposed (Symptoms, SPT, IgE) | 2000 | Germany | IgE | 42 | 16.700 | | | 5.4.1 - Source Exposed (Symptoms, SPT, IgE) | 2010 | Italy / Austria / Switzerland / Netherlands | IgE | 101 | 18.810 | 20101118, Bublin M
| | 5.4.1 - Source Exposed (Symptoms, SPT, IgE) | 2010 | Italy / Austria / Switzerland / Netherlands | IgE | 48 | 20.830 | 20101118, Bublin M
| | 5.4.1 - Source Exposed (Symptoms, SPT, IgE) | 2009 | Japan | IgE | 14 | 14.200 | 20090520, Yagami A
| | 5.4.1 - Source Exposed (Symptoms, SPT, IgE) | 2006 | Spain | IgE | 23 | 17.400 | 20060324, Sanz ML
| | 5.4.1 - Source Exposed (Symptoms, SPT, IgE) | 2002 | Spain | IgE | 31 | 41.900 | | | 6.2 - General Population (Adults) | 2012 | Sweden | IgE | 371 | 1.080 | 20120528, Patelis A
| | 6.5 - Occupational Exposure | 2012 | South Africa | IgE | 85 | 14.180 | 20120404, Singh T
| | 5.4.1 - Source Exposed (Symptoms, SPT, IgE) | 2002 | Spain | IgE (IB) | 31 | 32.200 | | | 5.2.1 - Source Exposed (Symptoms, SPT) | 2000 | Canada | SPT | 29 | 3.400 | | | 5.4.1 - Source Exposed (Symptoms, SPT, IgE) | 2009 | Japan | SPT | 14 | 13.300 | 20090520, Yagami A
| | 5.4.1 - Source Exposed (Symptoms, SPT, IgE) | 2002 | Spain | SPT | 31 | 93.500 | |
|
Loading...
Hev b 8
